Changes in vision require prompt attention, particularly if you have diabetes, as semaglutide has been associated with worsening of diabetic retinopathy in some patients with type 2 diabetes, as noted in the SmPC
No statements on this website have been evaluated by the FDA, and no claims are made regarding the safety, efficacy, or suitability of these materials for any purpose outside of controlled laboratory research
WEGOVY is not recommended in patients with severe gastroparesis
Tips For Those Using Semaglutide Injections Below are some of our top tips for those looking for guidance with their Semaglutide Embrace Smaller Portions Begin your weight loss journey by embracing the smaller portions strategy
Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection